Drug Formulation and Controlled Release Systems for the Gastrointestinal Tract
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 92
Special Issue Editors
Interests: inorganic, polymer and hybrid nanosystems; controlled release of active substances; biopharmaceutical control
Interests: polymer nanoparticles; drug delivery; dermal and transdermal drug delivery
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide an update on the current and recent progress in different drug formulation and controlled release systems (modified release tablets, nanoparticles, microneedle injectors or other devices) that can unlock options for drug and protein delivery to the gastrointestinal tract. They may possess suitable bioadhesion, pH-sensitive or microenvironment-triggered release properties, and active targeting. The possibility for oral or parenteral application would further improve the opportunities for therapy and diagnosis of diseases affecting the stomach, intestines, colon, liver or biliary tract. Such systems must offer advantages over traditional methods of drug delivery, including the tailoring of drug release rates, stability protection of drugs, and increased patient comfort and compliance.
We welcome researchers to contribute original research articles and reviews, with topics addressing, but not limited to, the key findings on and contributions to drug and protein delivery to the gastrointestinal tract and related structures via different delivery routes or strategies.
We look forward to receiving your contributions.
Dr. Borislav S. Tzankov
Dr. Christina Voycheva
Dr. Teodora Popova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastrointestinal diseases
- gastrointestinal tract
- gastrointestinal cancer
- colorectal cancer
- rectal cancer
- nanomedicine
- drug formulation
- drug delivery systems
- nanocarriers
- targeted drug delivery
- nanotechnology
- pharmaceutical science
- nano-bioengineering
